These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30852149)

  • 1. Current treatment of behavioral and cognitive symptoms of Parkinson's disease.
    Rektorova I
    Parkinsonism Relat Disord; 2019 Feb; 59():65-73. PubMed ID: 30852149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric Issues in Parkinson's Disease.
    Cooney JW; Stacy M
    Curr Neurol Neurosci Rep; 2016 May; 16(5):49. PubMed ID: 27048443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for non-motor symptoms in Parkinson's disease.
    Marinus J; Zhu K; Marras C; Aarsland D; van Hilten JJ
    Lancet Neurol; 2018 Jun; 17(6):559-568. PubMed ID: 29699914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.
    Trojano L; Papagno C
    Neurol Sci; 2018 Jan; 39(1):53-61. PubMed ID: 29038946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.
    Biundo R; Fiorenzato E; Antonini A
    Int Rev Neurobiol; 2017; 133():389-415. PubMed ID: 28802926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms in Parkinson's Disease.
    Aarsland D; Kramberger MG
    J Parkinsons Dis; 2015; 5(3):659-67. PubMed ID: 26406147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychiatric manifestations in Parkinson's disease].
    Oikonomou E; Paparrigopoulos T
    Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
    Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.
    Lizarraga KJ; Fox SH; Strafella AP; Lang AE
    Clin Geriatr Med; 2020 Feb; 36(1):105-118. PubMed ID: 31733691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
    Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA
    CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dementia and psychotic disorders in parkinsonism: common origin and new perspectives in therapy].
    Litvinenko IV
    Adv Gerontol; 2004; 13():94-101. PubMed ID: 15490731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric Manifestation in Patients with Parkinson's Disease.
    Han JW; Ahn YD; Kim WS; Shin CM; Jeong SJ; Song YS; Bae YJ; Kim JM
    J Korean Med Sci; 2018 Nov; 33(47):e300. PubMed ID: 30450025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Be vigilant for dementia in Parkinson’s disease.
    Niccolini F; Diamantopoulos K; Kiosses S; Politis M
    Practitioner; 2017 May; 261(1804):11-5. PubMed ID: 29120562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms.
    Meng D; Jin Z; Wang Y; Fang B
    CNS Neurosci Ther; 2023 Aug; 29(8):2259-2266. PubMed ID: 36924300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging behavioural complications of Parkinson's disease.
    Valli M; Mihaescu A; Strafella AP
    Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review.
    Koychev I; Okai D
    Evid Based Ment Health; 2017 Feb; 20(1):15-20. PubMed ID: 28073810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's Disease.
    Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
    J Parkinsons Dis; 2015; 5(3):541-8. PubMed ID: 26406134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.
    Maréchal E; Denoiseux B; Thys E; Crosiers D; Pickut B; Cras P
    J Neurol; 2015 Jan; 262(1):7-20. PubMed ID: 24824224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.